10% Off $75 Orders! Use Code SAVE10P Shop Now
One use per customer. Not available with Autoship. Expires 5/28/18.

Important Drug Warning and Prescribing Information for Zelnorm

1 Star2 Stars3 Stars4 Stars5 Stars (121 votes, average: 2.90 out of 5)
Loading...

The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation. This new information relates to a Warning for serious consequences of diarrhea and a Precaution for rare reports of ischemic colitis in post marketing use of Zelnorm.

Read the 2004 MedWatch safety summary, including links to the Dear Healthcare Professional letter, revised label and FDA Information page, at:

http://www.fda.gov/medwatch/SAFETY/2004/safety04.htm#zelnorm

1 Star2 Stars3 Stars4 Stars5 Stars (121 votes, average: 2.90 out of 5)
Loading...



Leave a Reply